CRCL is trading at $84.86 (-10.15%) after a rare analyst downgrade and news of insider selling spooked investors, leading to a sharp sell-off.
- Compass Point downgraded the stock from Neutral to Sell and cut its price target to $77, citing concerns over declining gross margins and a shift in its USDC stablecoin supply to lower-profit channels. [1, 3, 6]
- The downgrade was amplified by recent SEC filings that revealed insider selling by multiple company directors, adding to negative sentiment. [3, 5]
- The decline diverges sharply from broader market gains in the S&P 500 (+0.50%), highlighting significant company-specific bearish pressure.